Skip to main content Accessibility help
×
Hostname: page-component-8448b6f56d-tj2md Total loading time: 0 Render date: 2024-04-16T21:01:50.342Z Has data issue: false hasContentIssue false

Chap. 10 - BACTEREMIA, SEPSIS, SEPTIC SHOCK, AND TOXIC SHOCK SYNDROME

Published online by Cambridge University Press:  07 September 2011

Geeta Patel
Affiliation:
Montgomery Regional Hospital
Ryan Hawley
Affiliation:
Samaritan Medical Center
Noah Scheinfeld
Affiliation:
Columbia University College of Physicians and Surgeons
Ronni Wolf
Affiliation:
Kaplan Medical Center, Rehovot, Israel
Batya B. Davidovici
Affiliation:
Kaplan Medical Center, Rehovot, Israel
Jennifer L. Parish
Affiliation:
Jefferson Medical College of Thomas Jefferson University
Lawrence Charles Parish
Affiliation:
Jefferson Medical College of Thomas Jefferson University
Get access

Summary

IN THE EMERGENCY department, intensive care unit, and primary care setting, dermatological conditions rank as one of the most common disease presentations. It is often a challenge for physicians to differentiate routine skin ailments from more serious, life-threatening conditions that require immediate intervention. This chapter highlights some dermatologic emergencies that plague physicians daily and initially may present with cutaneous manifestations. Septic shock and toxic shock syndrome (TSS) are potentially fatal medical emergencies that manifest with dermatologic signs, making a good understanding of dermatology a crucial step in rapid and early diagnosis of these two emergencies. As part of a clinical continuum, the terms bacteremia, sepsis, and septic shock have for many years been confused due to the inaccurate usage of terminology associated with such infections. In 1991, the American College of Chest Physicians and the Society of Critical Care Medicine convened a Consensus Conference to standardize terminology and provide a framework for physicians to accurately identify the body's systemic response to infection. These quantifiable definitions work on a clinical continuum established by clinical and laboratory findings. Unfortunately, to date there is no single definitive census for the standard of care and defined illness; the 1992 consensus is commonly accepted and reputable for defining disease for this topic and will be used as a guideline for this chapter (Table 10.1).

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2011

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Bone, RC, Balk, RA, Cerra, FB, et al. Definition for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest. 1992; 101:1644–55.CrossRefGoogle Scholar
Strusbaugh, LJ, Joseph, CL. Epidemiology and prevention of infections in residents of long term care facilities In: Mayhall, CG 3rd, editor. Hospital epidemiology and infection control. Philadelphia: Lippincott Williams & Wilkins; 2004. p. 1869.Google Scholar
Brun-Buisson, C, Doyon, F, Carlet, J. Bacteremia and severe sepsis in adults: a multicenter prospective survey in ICUs and wards of 24 hospitals. French Bacteremia-Sepsis Study Group. Am J Respir Crit Care Med. 1996; 154:617–24.CrossRefGoogle ScholarPubMed
Girard, TD, Ely, EW. Bacteremia and sepsis in older adults. Clin Geriatr Med. 2007; 23:633–47.CrossRefGoogle ScholarPubMed
Greenberg, BM, Atmar, AL, Stager, CE, Greenberg, SB. Bacteraemia in the elderly: predictors of outcome in an urban teaching hospital. J Infect. 2005; 50:288–95.CrossRefGoogle Scholar
Lee, CC, Chen, SY, Chang, IJ, et al. Comparison of clinical manifestations and outcome of community-acquired bloodstream infections among the oldest old, elderly, and adult patients. Medicine. 2007; 86:138–44.Google Scholar
,National Center for Health Statistics. Leading causes of death. Center for Disease Control; 2008 [cited 2 May 2008]. Available at: http://www.cdc.gov/nchs/FASTATS/lcod.htm.
Angus, DC, Linde-Zwirble, WT, Lidicker, J, et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001; 29:1303–10.CrossRefGoogle ScholarPubMed
Dellinger, RP. Cardiovascular management of septic shock. Crit Care Med. 2003; 31:946–55.CrossRefGoogle ScholarPubMed
Martin, GS, Mannino, DM, Eaton, S, Moss, M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003; 348:1546–54.CrossRefGoogle ScholarPubMed
Watson, RS, Carcillo, JA, Linde-Zwirble, WT, et al. The epidemiology of severe sepsis in children in the United States. Am J Respir Crit Care Med. 2003; 167:695–701.CrossRefGoogle ScholarPubMed
Alberti, C, Brun-Buisson, C, Goodman, SV, et al. Influence of systemic inflammatory response syndrome and sepsis on outcome of critically ill infected patients. Am J Respir Crit Care Med. 2003; 168:77–84.CrossRefGoogle ScholarPubMed
Sands, KE, Bates, DW, Lanken, PN, et al. Epidemiology of sepsis syndrome in 8 academic medical centers. JAMA. 1997; 278;234–40.CrossRefGoogle ScholarPubMed
Brun-Buisson, C, Doyon, F, Carlet, J, et al. Incidence, risk factors, and outcome of severe sepsis and septic shock in adults: a multicenter prospective study in intensive care units. JAMA. 1995; 274:968–74.CrossRefGoogle ScholarPubMed
Catenacci, MH, King, K. Severe sepsis and septic shock: improving outcomes in the emergency department. Emerg Med Clin N Am. 2008; 26:603–23.CrossRefGoogle ScholarPubMed
Harris, RL, Muscher, DM, Bloom, K, et al. Manifestations of sepsis. Arch Intern Med. 1987; 147:1895–906.CrossRefGoogle ScholarPubMed
Talan, DA, Moran, GJ, Abrahamian, FM. Severe sepsis and septic shock in the emergency department. Infect Dis Clin N Am. 2008; 22:1–31.CrossRefGoogle ScholarPubMed
Cunha, BA. Sepsis and septic shock: selection of empiric antimicrobial therapy. Crit Care Clin. 2008; 24:313–34.CrossRefGoogle ScholarPubMed
Picard, KM, O'Donoghue, SC, Young-Kershaw, DA, Russell, KJ. Development and implementation of a multidisciplinary sepsis protocol. Crit Care Nurse. 2006; 26:43–54.Google ScholarPubMed
Todd, J, Fishaut, M, Kapral, F, Welch, T. Toxic-shock syndrome associated with phage-group 1 staphylococci. Lancet. 1978; ii:1116–18.CrossRefGoogle Scholar
Reingold, AL, Dan, BB, Shands, KN, Broome, CV. Toxic shock syndrome not associated with menstruation. Lancet. 1982; i:1–4.CrossRefGoogle Scholar
Hoge, CW, Schwartz, B, Talkington, DF, et al. The changing epidemiology of invasive group A streptococcal infections and the emergence of streptococcal toxic shock-like syndrome: a retrospective population-based study. JAMA. 1993; 269:384–9.CrossRefGoogle ScholarPubMed
,The Working Group on Severe Streptococcal Infections. Defining the group A streptococcal toxic shock syndrome: rationale and consensus definition. JAMA. 1993; 269:390–1.CrossRefGoogle Scholar
Davies, JP, Chesney, PJ, Wand, PJ, LaVenture, M. Toxic-shock syndrome: epidemiologic features, recurrence, risk factors and prevention. N Engl J Med. 1980; 303:1429–35.CrossRefGoogle Scholar
Chesney, JP, Davis, JP. Toxic shock syndrome. In: Feigin, RD, Cherry, JD, editors. Textbook of pediatric infectious diseases. 4th ed. Philadelphia: WB Saunders; 1998. pp. 830–52.Google Scholar
Chuang, Y, Huang, Y, Lin, T. Toxic shock syndrome in children: epidemiology, pathogenesis, and management. Pediatr Drugs. 2005; 7:11–25.CrossRefGoogle ScholarPubMed
Lowy, FD. Staphylococcus aureus infections. 1998; 339:520–32.PubMed
Stevens, DL. Invasive group A streptococcus infections. Clin Infect Dis. 1992; 14:2–11.CrossRefGoogle ScholarPubMed
Stevens, DL, Tanner, MH, Winship, J, et al. Severe group A streptococcal infections associated with a toxic shock–like syndrome and scarlet fever toxin A. N Engl J Med. 1989;321:1–7.CrossRefGoogle ScholarPubMed
Bradley, JS, Schlievert, PM, Sample, TG. Streptococcal toxic shock–like syndrome as a complication of varicella. Pediatr Infect Dis J. 1991; 10:77–8.CrossRefGoogle ScholarPubMed
Hribalova, V. Streptococcus pyogenes and the toxic shock syndrome. Ann Intern Med. 1988; 108:772.CrossRefGoogle ScholarPubMed
Luce, JM. Pathogenesis and management of septic shock. Chest. 1987; 91:883–8.CrossRefGoogle ScholarPubMed
Hotchkiss, RS, Karl, IE. The pathophysiology and treatment of sepsis. N Engl J Med. 2003; 348:138–50.CrossRefGoogle ScholarPubMed
Remick, DG. Pathophysiology of sepsis. Am J Pathol. 2007; 170:1435–44.CrossRefGoogle ScholarPubMed
Arbour, NC, Lorenz, E, Schutte, BC, et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet. 2005; 25:187–91.Google Scholar
Underhill, DM, Ozinsky, A.Toll-like receptors: key mediators of microbe infection. Curr Opin Immunol. 2002; 14:103–10.CrossRefGoogle Scholar
Opal, SM, Gluck, T. Endotoxin as a drug target. Crit Care Med. 2003; 31:S57–S64.CrossRefGoogle ScholarPubMed
Beutler, B, Rietschel, ET. Innate immune sensing and its roots: the story of endotoxin. Nat Rev Immunol. 2003; 3:169–76.CrossRefGoogle ScholarPubMed
Akira, S, Uematsu, S, Takeuchi, O. Pathogen recognition and innate immunity. Cell. 2006; 124:783–801.CrossRefGoogle ScholarPubMed
Beutler, B, Jiang, Z, Georgel, P, et al. Genetic analysis of host resistance: Toll-like receptor signaling and immunity at large. Annu Rev Immunol. 2006; 24:353–89.CrossRefGoogle ScholarPubMed
Munoz, C, Carlett, J, Ritting, C. Dysregulation of in vitro cytokine production by monocytes during sepsis. J Clin Invest. 1991; 88:1747–54.CrossRefGoogle ScholarPubMed
Bohach, GA, Fast, DJ, Nelson, RD, Schlievert PM. Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses. Crit Rev Microbiol. 1990; 17:251–72.CrossRefGoogle ScholarPubMed
Schmitt, CK, Meysick, KC, O'Brien, AD. Bacterial toxins: friends or foes?Emerg Infect Dis. 1999; 5:224–34.CrossRefGoogle ScholarPubMed
Proft, T, Sriskandan, S, Yang, L, Fraser, JD. Superantigens and streptococcal toxic shock syndrome. Emerg Infect Dis. 2003; 9:1211–18.CrossRefGoogle ScholarPubMed
Sriskandan, S, Ferguson, M, Elliot, V, et al. Human intravenous immunoglobulin for experimental streptococcal toxic shock: bacterial clearance and modulation of inflammation. J Antimicrob Chemother. 2006; 58:117–24.CrossRefGoogle ScholarPubMed
King, C. Evaluation and management of febrile infants in the emergency department. Emerg Med Clin N Am. 2003; 21:89–99.CrossRefGoogle ScholarPubMed
Martin, GS, Mannino, DM, Moss, M. The effect of age on the development and outcome of adult sepsis. Crit Care Med. 2006; 34:15–21.CrossRefGoogle ScholarPubMed
Sprung, CL, Peduzzi, PN, Shatney, CH, et al. The impact of encephalopathy on mortality and physiologic derangements in the sepsis syndrome. Crit Care Med. 1988; 16:398–405.CrossRefGoogle Scholar
Kreger, BE, Craven, , Carling, PC, McCabe, WR. Gram-negative bacteremia. III. Reassessment of etiology, epidemiology and ecology in 612 patients. Am J Med. 1980; 68:332–43.CrossRefGoogle ScholarPubMed
Vincent, JL. Clinical sepsis and septic shock - definition, diagnosis and management principles. Langenbecks Arch Surg. 2008; 393:817–24.CrossRefGoogle ScholarPubMed
Iberti, TJ, Bone, RC, Balk, R, et al. Are the criteria used to determine sepsis applicable for patients 75 years of age?Crit Care Med. 1993; 21:S130.CrossRefGoogle Scholar
Musher, D. Cutaneous and soft-tissue manifestations of sepsis due to gram-negative enteric bacilli. Rev Infect Dis. 1980; 2:854–66.CrossRefGoogle ScholarPubMed
El Baze, P, Ortonne, JP. Ecthyma gangrenosum. J Am Acad Dermatol. 1985; 13:299–300.CrossRefGoogle ScholarPubMed
Huminer, D, Siegman-Igra, Y, Morduchowicz, G, Pitlik, SD. Ecthyma gangrenosum without bacteremia. Report of six cases and review of the literature. Arch Intern Med. 1987; 147:299–310.CrossRefGoogle ScholarPubMed
Gucluer, H, Ergun, T, Demircay, Z. Ecthyma gangrenosum. Int J Dermatol. 1999; 38:298–305.CrossRefGoogle ScholarPubMed
Brogan, PA, Raffles, A. The management of fever and petechiae: making sense of rash decisions. Arch Dis Child. 2000; 83:506–7.CrossRefGoogle ScholarPubMed
Crowson, AN, Mihm, MC, Magro, CM. Cutaneous vasculitis: a review. J Cutan Pathol. 2003; 30:161–73.CrossRefGoogle ScholarPubMed
Macke, SE, Jordon, RE. Leukocytoclastic vasculitis. A cutaneous expression of immune complex disease. Arch Dermatol. 1982; 118:296.Google Scholar
Dagan, R, Powell, KR, Hall, CB, Menegus, MA. Identification of infants unlikely to have serious bacterial infection although hospitalized for suspected sepsis. J Pediatr. 1985; 107:855–60.CrossRefGoogle ScholarPubMed
Nguyen, Q, Nguyen, EA, Weiner, LB. Incidence of invasive disease in children with fever and petechiae. Pediatrics. 1984; 74:77–80.Google ScholarPubMed
Deuren, M, Dijke, BJ, Koopman, RJ, et al. Rapid diagnosis of acute meningococcal infections by needle aspiration or biopsy of skin lesions. BMJ. 1993; 306:1229–32.CrossRefGoogle ScholarPubMed
Robboy, SJ, Mihm, MC, Colman, RW, Minna, JD. The skin in disseminated intravascular coagulation. Prospective analysis of thirty-six cases. Br J Dermatol. 1973; 88:221–9.CrossRefGoogle ScholarPubMed
Jackson, RT, Luplow, RE. Adult purpura fulminans and digital necrosis associated with sepsis and the factor V mutation. JAMA. 1998; 280:1829–30.CrossRefGoogle ScholarPubMed
Bisharat, N, Agmon, V, Fenkelstein, R.Clinical, epidemiological and microbiological features of Vibrio vulnificus biogroup 3 causing outbreaks of wound infection and bacteraemia in Israel. Lancet. 1999; 354:1421–4.CrossRefGoogle ScholarPubMed
Fujisawa, N, Yamada, H, Kohda, H, et al. Necrotizing fasciitis caused by Vibrio vulnificus differs from that caused by streptococcal infection. J Infect. 1998; 36:3113–16.CrossRefGoogle ScholarPubMed
Swartz, MN. Cellulitis and subcutaneous tissue infections. In: Mandell, GL, editor. Principles and practice of infectious diseases. 5th ed. New York: Churchill Livingstone; 2000. pp. 1042–5.Google Scholar
Bisno, AL, Stevens, DL. Streptococcal infections of skin and soft tissues. N Engl J Med. 1996; 334:240–5.CrossRefGoogle ScholarPubMed
Bolton, CF, Young, GB, Zochodne, DW. The neurological complications of sepsis. Ann Neurol. 1993; 33:94–100.CrossRefGoogle ScholarPubMed
Sprung, CL, Peduzzi, PN, Shatney, CH, et al. Impact of encephalopathy on mortality in the sepsis syndrome. Crit Care Med. 1990; 18:801–5.CrossRefGoogle ScholarPubMed
Gao, F, Melody, T, Daniels, DF, et al. The impact of compliance with 6-hour and 24-hour sepsis bundles on hospital mortality in patients with severe sepsis: a prospective observational study. Crit Care. 2005; 9:R764–70.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×